Medpace Holdings, INC Form 4 insider transactions

Cornelius P. McCarthy III, a director at Medpace Holdings, exercised stock options on March 31, 2024, resulting in the acquisition of 63 shares of common stock.

Brian T. Carley, a director at Medpace Holdings, exercised stock options on March 31, 2024, resulting in the acquisition of 79 shares of common stock.

Susan Burwig, Executive VP of Operations at Medpace Holdings, sold 102 shares of common stock on March 15, 2024.

Ashley M. Keating, a director at Medpace Holdings, exercised stock options and sold shares on March 14, 2024.

Medpace Holdings CEO August J. Troendle sold 200,000 shares of common stock over three days in March 2024, through Medpace Investors, LLC.

Medpace Investors, LLC, a 10% owner of Medpace Holdings, Inc., sold 200,000 shares of common stock over three days in early March.

Director Ashley M. Keating exercised stock options and sold shares of Medpace Holdings, Inc. on March 7, 2024.

Medpace Holdings President Jesse Geiger exercised stock options and sold shares on March 4th and 5th, 2024, according to a Form 4 filing with the SEC.

Medpace Holdings CEO August J. Troendle sold 100,000 shares of common stock in two separate transactions on March 4th and 5th, 2024, at weighted average prices of $403.12 and $402.70, respectively.

Medpace Investors, LLC, a 10% owner of Medpace Holdings, Inc., sold 100,000 shares of common stock over two days in March 2024.

Medpace Investors, LLC, a 10% owner of Medpace Holdings, Inc., sold 100,000 shares of common stock in two transactions on February 29, 2024, and March 1, 2024.

Medpace Holdings CEO August J. Troendle indirectly sold 100,000 shares of common stock through Medpace Investors, LLC on February 29 and March 1, 2024.

Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., sold shares of common stock to cover tax withholding obligations and for general trading.

Jesse J. Geiger, President of Medpace Holdings, Inc., sold 2,558 shares of common stock on February 29, 2024, to satisfy tax withholding obligations.

Ashley M. Keating, a director at Medpace Holdings, exercised stock options and sold 500 shares of common stock on February 28, 2024.

Medpace Holdings CEO August J. Troendle, through Medpace Investors, LLC, sold 100,000 shares of common stock in two days at weighted average prices of $401.88 and $404.13.

Medpace Investors, LLC, a 10% owner of Medpace Holdings, Inc., sold 100,000 shares of common stock in two transactions on February 27 and 28, 2024.

Ashley M. Keating, a director at Medpace Holdings, exercised stock options and sold shares on February 26, 2024, according to a Form 4 filing with the SEC.

Medpace Holdings CEO August J. Troendle reports the sale of company stock through Medpace Investors, LLC.

Medpace Investors, LLC, a 10% owner of Medpace Holdings, Inc., sold a significant number of shares in two transactions on February 23 and 26, 2024.